Skip to content
10-Q

Quarterly Report

Deciphera Pharmaceuticals, Inc.

0001654151-23-000019

← back to feed
Filed
Oct 30, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Oct 26, 2023 80.12M sh
Shares Diluted Q3 2023 · Sep 30, 2023 85.79M sh
Shares Diluted Q3 2023 · Sep 30, 2023 84.51M sh
Shares Diluted Q3 2023 · Sep 30, 2022 78.21M sh
Shares Diluted Q3 2023 · Sep 30, 2022 73.13M sh
Capex Q3 2023 · Sep 30, 2023 $715K
Capex Q3 2023 · Sep 30, 2022 $860K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$117.89M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$117.7M
Cash And Equivalents Q3 2023 · Sep 30, 2023 $108.09M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $64.74M
Stockholders Equity Q3 2023 · Sep 30, 2023 $381.67M
Stockholders Equity Q3 2023 · Jun 30, 2023 $404.43M
Stockholders Equity Q3 2023 · Dec 31, 2022 $341.69M
Stockholders Equity Q3 2023 · Sep 30, 2022 $373.78M
Stockholders Equity Q3 2023 · Jun 30, 2022 $405.01M
Stockholders Equity Q3 2023 · Dec 31, 2021 $304.72M
Current Liabilities Q3 2023 · Sep 30, 2023 $92.89M
Current Liabilities Q3 2023 · Dec 31, 2022 $86.47M
Total Liabilities Q3 2023 · Sep 30, 2023 $116.17M
Total Liabilities Q3 2023 · Dec 31, 2022 $112.35M
Current Assets Q3 2023 · Sep 30, 2023 $417.58M
Current Assets Q3 2023 · Dec 31, 2022 $392.96M
Total Assets Q3 2023 · Sep 30, 2023 $497.84M
Total Assets Q3 2023 · Dec 31, 2022 $454.04M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.58
Eps Diluted Q3 2023 · Sep 30, 2023 −$1.75
Eps Diluted Q3 2023 · Sep 30, 2022 −$0.55
Eps Diluted Q3 2023 · Sep 30, 2022 −$1.82
Eps Basic Q3 2023 · Sep 30, 2023 −$0.58
Eps Basic Q3 2023 · Sep 30, 2023 −$1.75
Eps Basic Q3 2023 · Sep 30, 2022 −$0.55
Eps Basic Q3 2023 · Sep 30, 2022 −$1.82
Sga Expense Q3 2023 · Sep 30, 2023 $33.25M
Sga Expense Q3 2023 · Sep 30, 2023 $97.31M
Sga Expense Q3 2023 · Sep 30, 2022 $30.03M
Sga Expense Q3 2023 · Sep 30, 2022 $87.97M
Rd Expense Q3 2023 · Sep 30, 2023 $62.46M
Rd Expense Q3 2023 · Sep 30, 2023 $175.52M
Rd Expense Q3 2023 · Sep 30, 2022 $47.49M
Rd Expense Q3 2023 · Sep 30, 2022 $139.76M
Net Income Q3 2023 · Sep 30, 2023 −$49.58M
Net Income Q3 2023 · Sep 30, 2023 −$147.75M
Net Income Q3 2023 · Mar 31, 2023 −$178.9M
Net Income Q3 2023 · Sep 30, 2022 −$43.04M
Net Income Q3 2023 · Sep 30, 2022 −$133M
Operating Income Q3 2023 · Sep 30, 2023 −$53.69M
Operating Income Q3 2023 · Sep 30, 2023 −$159.72M
Operating Income Q3 2023 · Sep 30, 2022 −$44.88M
Operating Income Q3 2023 · Sep 30, 2022 −$135.56M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $1.29M
Cost Of Revenue Q3 2023 · Sep 30, 2023 $1.95M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $3.34M
Cost Of Revenue Q3 2023 · Sep 30, 2022 $5.53M
Revenue Q3 2023 · Sep 30, 2023 $43.31M
Revenue Q3 2023 · Sep 30, 2023 $115.06M
Revenue Q3 2023 · Sep 30, 2022 $35.97M
Revenue Q3 2023 · Sep 30, 2022 $97.69M